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Results and Conclusions
There is evidence that the human microbiota can affect the risk of developing
cancer, as well as the response to treatment during the disease. Inflammation as an
immunological response to the presence of bacteria that promote the development
of cancer is the most accepted mechanism to explain the microbiome-cancer
relationship. The fact that effectiveness of chemotherapy treatments depends on
the presence of certain bacteria can be based on the immune response that
produces inflammation in the presence of some microorganisms. Inflammatory
bowel disease is caused by a complex interrelation between genetic, environmental
and intestinal microbes. New metagenomic techniques have been essential in the
study of intestinal microbiota and cancer. It would be interesting to conduct
intestinal microbiota studies in people with predisposition to colon cancer, who
have not yet developed it, and in people with colon cancer at different stages to
check if a stool analysis can be predictive of the patient's condition. It is necessary
to carry out studies that indicate if a treatment with prebiotics and probiotics is
able to help fight some pathologies.
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Introduction
Cancer is a disease of multifactorial etiology in whose genesis different
microorganisms could be involved. The intestinal microbiota is the set of
microorganisms that make up the intestinal flora. Colorectal cancer may be
influenced by changes in the intestinal microbiota that affect the mucosa and
cause an immune response capable of producing inflammatory effects. Although
there are still few studies in this regard, it is necessary to emphasize the need to
expand the studies on this topic and to state the usefulness of the new
technologies based on metagenomics.
Objectives
To study the current state of knowledge about the relationship between intestinal
microbiota and colorectal cancer. To highlight the need to expand these studies
taking advantage of new technologies based on metagenomics for the study of
intestinal microbiota.
Material and methods
A review of 75 journal articles in different multidisciplinary databases (Scopus,
Pubmed, Medline ...) was carried out using the following keywords: “Intestinal
microbiota”, “Gut microbiota”, “Colorectal cancer”, “Intestinal microbiota and
colorectal cancer” “Metagenomic and microbiota”.
Figure 1: Roll of gut microbiote. Amon P., Sanderson I., 
What is the microbiome?, Archives of Disease in Childhood –
Education and Practice 102(5): edpract-2016-311643, 2017. 
Figure 2: Histopathologic image of colonic carcinoid
stained by hematoxylin and eosin. GNU.
Figure 3: Photograph of a carcinoma of the ascending colon 
during a colonoscopy. A biopsy is taken with the instrument at 
the lower edge of the picture. Doctor Silke.
Figure 4: Colorectal cancer progression. 
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